Cargando…
Insight into the Evolving Role of PCSK9
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is the last discovered member of the family of proprotein convertases (PCs), mainly synthetized in hepatic cells. This serine protease plays a pivotal role in the reduction of the number of low-density lipoprotein receptors (LDLRs) on the surface...
Autores principales: | Maligłówka, Mateusz, Kosowski, Michał, Hachuła, Marcin, Cyrnek, Marcin, Bułdak, Łukasz, Basiak, Marcin, Bołdys, Aleksandra, Machnik, Grzegorz, Bułdak, Rafał Jakub, Okopień, Bogusław |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951079/ https://www.ncbi.nlm.nih.gov/pubmed/35323699 http://dx.doi.org/10.3390/metabo12030256 |
Ejemplares similares
-
Pleiotropic Effects of PCSK-9 Inhibitors
por: Basiak, Marcin, et al.
Publicado: (2021) -
The Effect of PCSK9 Inhibition on the Stabilization of Atherosclerotic Plaque Determined by Biochemical and Diagnostic Imaging Methods
por: Basiak, Marcin, et al.
Publicado: (2023) -
Metformin reduces the expression of NADPH oxidase and increases the expression of antioxidative enzymes in human monocytes/macrophages cultured in vitro
por: Bułdak, Łukasz, et al.
Publicado: (2017) -
Effect of PCSK9 Inhibitors on Hemostasis in Patients with Isolated Hypercholesterolemia
por: Basiak, Marcin, et al.
Publicado: (2022) -
Impact of PCSK9 Inhibition on Proinflammatory Cytokines and Matrix Metalloproteinases Release in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque
por: Basiak, Marcin, et al.
Publicado: (2022)